{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T06:47:36Z","timestamp":1750747656606},"reference-count":0,"publisher":"BioExcel","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DIC"],"DOI":"10.7573\/dic.2023-2-6","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T14:49:27Z","timestamp":1692715767000},"page":"1-9","source":"Crossref","is-referenced-by-count":3,"title":["Precautions in the management of opioid agonist therapy: from target population characteristics to new formulations and post-marketing monitoring \u2013 a focus on the Italian system"],"prefix":"10.7573","volume":"12","author":[{"given":"Guido","family":"Mannaioni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Lugoboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10047","published-online":{"date-parts":[[2023,8,24]]},"container-title":["Drugs in Context"],"original-title":[],"link":[{"URL":"https:\/\/www.drugsincontext.com\/wp-content\/uploads\/2023\/08\/dic.2023-2-6.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T14:49:28Z","timestamp":1692715768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.drugsincontext.com\/precautions-in-the-management-of-opioid-agonist-therapy-from-target-population-characteristics-to-new-formulations-and-post-marketing-monitoring-a-focus-on-the-italian-system"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":0,"URL":"https:\/\/doi.org\/10.7573\/dic.2023-2-6","relation":{},"ISSN":["1740-4398"],"issn-type":[{"value":"1740-4398","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,24]]}}}